Skip to content

Serum HDAC6 Levels and the Severity and Prognosis of Patients With Acute Ischemic Stroke

Serum HDAC6 Levels and the Severity and Prognosis of Patients With Acute Ischemic Stroke

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018814
Enrollment
Unknown
Registered
2018-10-11
Start date
2018-10-07
Completion date
Unknown
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Comply with the diagnostic criteria revised in China's Acute Ischemic Stroke Diagnosis and Treatment Guide 2018, and confirmed by computed tomography (CT) or magnetic resonance imaging (MRI); 2. The incidence of blood sampling time = 72 h and received treatment in our hospital; 3. Aged 18-80 years old; 4. The patient is the first onset, or the recurrent disease of the limb sequelae that does not affect the neurological function score; 5. Patients and their families sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Parenchymal hemorrhage, subarachnoid hemorrhage, hemorrhagic cerebral infarction, or bleeding tendency; 2. Cerebral infarction caused by tumors, parasites, brain trauma and the like; 3. Patients with serious diseases such as heart, liver, kidney, lung and other vital organs and multiple organ failure; 4. Patients with severe systemic diseases, blood diseases, collagen diseases, connective tissue diseases, infectious diseases, endocrine and metabolic diseases (excluding diabetes); 5. Patients with previous neurological diseases and severe sequelae or other patients with severe physical illnesses who cannot be matched for examination; 6. Accompanied by malignant tumors; 7. Pregnancy or lactation; 8. A history of alcoholism, drug dependence or dementia; 9. Mental illness or communication difficulties.

Design outcomes

Primary

MeasureTime frame
HDAC6 expression level in blood;NIHSS score;mRS score;

Countries

China

Contacts

Public ContactYe Xinchun

Affiliated Hospital of Xuzhou Medical University

xinchunye@gmail.com+86 18052268829

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026